Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA Mitomycin-C GDSC1000 pan-cancer AAC 0.041 0.2
mRNA NG-25 GDSC1000 pan-cancer AAC 0.035 0.2
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC 0.17 0.3
mRNA PI-103 GDSC1000 pan-cancer AAC 0.035 0.3
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.04 0.3
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.3
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.071 0.3
mRNA VX-680 CTRPv2 pan-cancer AAC 0.14 0.3
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.052 0.3
mRNA etomoxir CTRPv2 pan-cancer AAC 0.049 0.3
Download CSV